SCHEMBL9866486

SCHEMBL9866486

CC(SCCNC(=S)NC(=O)c1ccccc1)c1ccccc1

nearest known ligand 0.56

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 11/20 0.56
ALOX12 P18054 4/20 0.56
SMN1; SMN2 Q16637 4/20 0.55
MITF O75030 1/20 0.51
RAB9A P51151 1/20 0.49
MEN1 O00255 3/20 0.48
KMT2A Q03164 3/20 0.48
CYP1A2 P05177 1/20 0.48
CYP3A4 P08684 1/20 0.48
CYP2C9 P11712 1/20 0.48
HPGD P15428 1/20 0.47
KDM4E B2RXH2 2/20 0.46
LMNA P02545 2/20 0.46
RECQL P46063 1/20 0.46
POLB P06746 1/20 0.46
GAA P10253 2/20 0.46
EPHX1 P07099 1/20 0.46
ACHE P22303 1/20 0.46
MAPT P10636 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9771085 0.87 ALDH1A1 (0.58) ALDH1A1ALOX12SMN1; SMN2MITFRAB9A
SCHEMBL9771127 0.84 ALDH1A1 (0.57) ALDH1A1ALOX12SMN1; SMN2MITFRAB9A
SCHEMBL9771230 0.81 ALDH1A1 (0.57) ALDH1A1ALOX12SMN1; SMN2MITFRAB9A
SCHEMBL15328470 0.79 ALDH1A1 (0.78) ALDH1A1ALOX12SMN1; SMN2MITFRAB9A
SCHEMBL9771140 0.78 EPHX2 (0.71) ALDH1A1ALOX12SMN1; SMN2MITFRAB9A
SCHEMBL28660632 0.78 MTNR1A (0.58) ALDH1A1KMT2AMAPT
SCHEMBL14946919 0.76 ALDH1A1 (0.69) ALDH1A1ALOX12SMN1; SMN2MITFRAB9A
SCHEMBL26512476 0.76 ALDH1A1 (0.69) ALDH1A1ALOX12SMN1; SMN2MITFRAB9A
SCHEMBL15328268 0.76 SMN1; SMN2 (0.77) ALDH1A1ALOX12SMN1; SMN2MITFRAB9A
SCHEMBL28982552 0.74 ALDH1A1 (0.71) ALDH1A1ALOX12SMN1; SMN2MITFRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5021431-A H-1 antagonist, h-2 agonist for treating hypertension, cardiac disease or arterial occlusion HEUMANN PHARMA GMBH & CO. (DE) 1991-06-04 US disclosed